Panuveitis following mRNA-based COVID-19 vaccine
Journal Français d'Ophtalmologie · 2023
DOI: 10.1016/j.jfo.2022.10.002 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal Français d'Ophtalmologie, 2023. Verfasst von A Bouayad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy Tangier, Abdelmalek Essaâdi University, Tangier, Morocco; Department of Ophthalmology, University Hospital of Tangie…. Hauptthemen laut MEDLINE: COVID-19, Panuveitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy Tangier, Abdelmalek Essaâdi University, Tangier, Morocco; Department of Ophthalmology, University Hospital of Tangier, Tangier, Morocco. Electronic address: Bouayad2228@gmail.com.
- Faculty of Medicine and Pharmacy Tangier, Abdelmalek Essaâdi University, Tangier, Morocco; Department of Ophthalmology, University Hospital of Tangier, Tangier, Morocco.
Zitieren
APA
Bouayad, A., Khodriss, C., Majidi, I., & Elbahloul, M. (2023). Panuveitis following mRNA-based COVID-19 vaccine. Journal Français d'Ophtalmologie. https://doi.org/10.1016/j.jfo.2022.10.002
Vancouver
Bouayad A, Khodriss C, Majidi I, Elbahloul M. Panuveitis following mRNA-based COVID-19 vaccine. Journal Français d'Ophtalmologie. 2023. doi:10.1016/j.jfo.2022.10.002
BibTeX
@article{Bouayad2023,
author = {Bouayad, A and Khodriss, C and Majidi, I and Elbahloul, M},
title = {Panuveitis following mRNA-based COVID-19 vaccine},
journal = {Journal Français d'Ophtalmologie},
year = {2023},
doi = {10.1016/j.jfo.2022.10.002}
}
EUVIMED